Islet Management’s Exact Sciences EXAS Stock Holding History

Islet Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-50,000	Closed	-$6.63M	–	181
2020 Q4	$6.63M	Buy	+50,000	New	+$6.05M	0.3%	87

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Islet Management's EXAS Position: Q1 2021 in Review

Islet Management sold out of Exact Sciences (EXAS) in Q1 2021, closing a stake of 50,000 shares — an estimated $6.63M sold.

Islet Management first reported a position in EXAS in Q4 2020 and held it in 1 quarter. The position peaked at $6.63M in Q4 2020. 645 funds tracked by Wall St. Rank hold EXAS as of Q1 2021.

Islet Management reported no remaining Exact Sciences position as of Q1 2021 after selling out during the quarter.
Islet Management sold 50,000 Exact Sciences shares in Q1 2021, an estimated $6.63M.
Islet Management first reported a position in Exact Sciences in Q4 2020 and held it in 1 quarter.
Islet Management's Exact Sciences position peaked at $6.63M in Q4 2020.
645 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2021.

Based on Islet Management's 13F filing for Q1 2021, filed 17 May 2021.